US 7351718
Substituted pyrrolidine and related compounds
granted A61KA61K31/40A61P
Quick answer
US patent 7351718 (Substituted pyrrolidine and related compounds) held by Theravance, Inc. expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/40, A61P, A61P11/06, A61P11/08